UPDATE 1-EU drugs panel recommends first-line Erbitux use - Reuters

May 30th, 2008 by admin
UPDATE 1-EU drugs panel recommends first-line Erbitux use
Reuters -2 hours ago
By Ben Hirschler LONDON, May 30 (Reuters) - The European Medicines Agency has recommended approval of cancer drug Erbitux as a first-line treatment for bowel cancer that has spread, boosting the product's sales potential in Europe.
Merck KGaA says Erbitux receives positive opinion from EU's CHMP Forbes
Merck KGaA's Erbitux Gets EU Backing for Wider Use (Update2)Bloomberg
CNNMoney.com - Marketplace - The Star-Ledger - NJ.com - Business Wire (press release)
all 34 news articles

More: continued here

Posted in Uncategorized

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.